Cover Image for Overcoming Cell and Gene Therapy Manufacturing Roadblocks: How Strategic Partnerships Enable Robust Early-Stage Clinical Manufacturing

Overcoming Cell and Gene Therapy Manufacturing Roadblocks: How Strategic Partnerships Enable Robust Early-Stage Clinical Manufacturing

 
 
Registration
Past Event
Welcome! To join the event, please register below.
About Event

​Cell and gene therapies offer the promise of transformative treatments, but they come with tremendous process development and manufacturing challenges.

​When sponsors aim to expedite their journey from concept to clinical trials, they face a pivotal decision: whether to establish internal capabilities or collaborate with specialized Contract Development and Manufacturing Organizations (CDMOs) to chart a cost-efficient course forward.

​This talk will explore how leveraging collaborative partnerships can help guide a rapid transition into first-in-human studies.

​Attendees will gain insights into process development cases from upstream to downstream manufacturing of drug substances (plasmid DNA, AAV, LVV, mRNA) and drug products (clinical cell therapy).